Target intelligence / Profile preview

phosphatidylinositol glycan anchor biosynthesis class P pseudogene 3 (PIGPP3)

Target
PIGPP3
01

Overview

The name "phosphatidylinositol glycan anchor biosynthesis class P pseudogene 3" implies a pseudogene (a non-functional gene copy) that may be related to PIGP, which is an enzyme required for the biosynthesis of GPI anchors, structures that tether certain proteins to the cell membrane. However, "PIGPP3" is not described as a protein-coding gene, receptor, enzyme, or recognized therapeutic target. There is no evidence of function, disease association, or drug interaction in the literature or curated gene/protein databases (e.g., NCBI Gene, UniProt, GeneCards). If the intent was to refer to a functional member of the PIG gene family (e.g., PIGP), those are classified as enzymes involved in GPI anchor synthesis, but "PIGPP3" itself does not appear to exist as a validated biological entity. The gene "PIGPP3" appears to be incorrectly named or possibly a hypothetical/erroneous entry; it is best categorized as a pseudogene (if it exists at all), not a therapeutic target, and there is no credible evidence or data to suggest biological function, clinical utility, or relevance for drug discovery.

Beyond the preview

Go deeper on phosphatidylinositol glycan anchor biosynthesis class P pseudogene 3 (PIGPP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on phosphatidylinositol glycan anchor biosynthesis class P pseudogene 3 (PIGPP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call